Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.185
-0.012 (-5.91%)
At close: Nov 4, 2024, 4:00 PM
0.182
-0.003 (-1.73%)
Pre-market: Nov 5, 2024, 4:45 AM EST

Company Description

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.

It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.

The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics.

The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services.

The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product’s naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security.

The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002.

Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Applied DNA Sciences, Inc.
Applied DNA Sciences logo
Country United States
Founded 1983
Industry Diagnostics & Research
Sector Healthcare
Employees 55
CEO James Hayward

Contact Details

Address:
50 Health Sciences Drive
Stony Brook, New York 11790
United States
Phone 631 240 8800
Website adnas.com

Stock Details

Ticker Symbol APDN
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0000744452
CUSIP Number 03815U300
ISIN Number US03815U3005
Employer ID 59-2262718
SIC Code 8734

Key Executives

Name Position
Dr. James A. Hayward Ph.D., Sc.D. Chairman, President and Chief Executive Officer
Beth M. Jantzen CPA Chief Financial Officer
Judith Murrah Chief Operating Officer, Chief Information Officer and Secretary
Clay Shorrock Esq., J.D. Chief Legal Officer and Executive Director of Business Development
Sanjay M. Hurry Executive Director of Investor Relations and Corporate Communications

Latest SEC Filings

Date Type Title
Oct 31, 2024 424B5 Filing
Oct 31, 2024 8-K Current Report
Oct 2, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 30, 2024 8-K Current Report
Sep 30, 2024 S-8 Securities to be offered to employees in employee benefit plans
Sep 18, 2024 8-K Current Report
Aug 21, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Aug 21, 2024 DEF 14A Other definitive proxy statements
Aug 19, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Aug 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals